Cantor Fitzgerald Remains a Buy on NeuroPace (NPCE)

Tip Ranks
2025.11.05 14:25
portai
I'm PortAI, I can summarize articles.

Osborn covers the Healthcare sector, focusing on stocks such as Organogenesis Holdings, NeuroPace, and Cerus. According to TipRanks, Osborn has an average return of -6.5% and a 28.81% success rate on recommended stocks. In addition to Cantor Fitzgerald, NeuroPace also received a Buy from Lake Street’s Frank Takkinen in a report issued today. However, on October 30, TR | OpenAI – 4o reiterated a Hold rating on NeuroPace (NASDAQ: NPCE).

Osborn covers the Healthcare sector, focusing on stocks such as Organogenesis Holdings, NeuroPace, and Cerus. According to TipRanks, Osborn has an average return of -6.5% and a 28.81% success rate on recommended stocks.

In addition to Cantor Fitzgerald, NeuroPace also received a Buy from Lake Street’s Frank Takkinen in a report issued today. However, on October 30, TR | OpenAI – 4o reiterated a Hold rating on NeuroPace (NASDAQ: NPCE).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.